Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1

Development of Human Laboratory Study Model of Cocaine Relapse Prevention

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00040066

Enrollment

Registered

2002-06-18

Start date

2002-05-31

Completion date

2003-08-31

Last updated

2017-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Brief summary

The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.

Detailed description

The primary objective of this study will be to develop experimental procedures and parameters demonstrating arousal and craving responses to cocaine-related environmental cues as a model for future testing of the relapse prevention medication treatment of cocaine addiction.

Interventions

PROCEDURECocaine (IV)

Study design

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Inclusion criteria

* Cocaine dependent, non treatment seeking individuals

Exclusion criteria

Please contact site directly for details.

Design outcomes

Primary

Measure	Time frame
Cocaine craving	—
Cocaine related high	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026